Literature DB >> 1483296

Oncogenous osteomalacia and malignancy.

J N Harvey1, C Gray, P E Belchetz.   

Abstract

An example of oncogenous osteomalacia is described in association with the rate mesenchymal chondroblastoma. The tumour was characterized with a variety of immunohistochemical antibodies which confirmed its mesenchymal origin. Despite several surgical excisions of local recurrence, plasma 1,25-dihydroxyvitamin D3 concentrations (off treatment) indicate continued tumour activity and the continuing need for vitamin D therapy. This case and two others briefly discussed illustrate some of the difficulties in diagnosis and in achieving a cure in cases of oncogenous osteomalacia. Oncogenous osteomalacia in association with any malignant tumour is rare, there being eight previously recorded cases. Details of these cases are briefly reviewed for comparison. Despite undoubted malignancy our patient has survived 30 years from presentation indicating the benefits of aggressive surgical management.

Entities:  

Mesh:

Year:  1992        PMID: 1483296     DOI: 10.1111/j.1365-2265.1992.tb02342.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

Review 1.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 2.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

3.  Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy.

Authors:  Valentina D Tarasova; Alejandro G Trepp-Carrasco; Robert Thompson; Robert R Recker; William H Chong; Michael T Collins; Laura A G Armas
Journal:  J Clin Endocrinol Metab       Date:  2013-09-06       Impact factor: 5.958

4.  Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia.

Authors:  Clemens Bergwitz; Michael T Collins; Ravi S Kamath; Andrew E Rosenberg
Journal:  N Engl J Med       Date:  2011-10-27       Impact factor: 91.245

5.  Varied presentation of sinonasal phosphaturic mesenchymal tumour: report of a case series with follow-up.

Authors:  Regi Kurien; Vedantam Rupa; Meera Thomas
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-16       Impact factor: 2.503

6.  A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis.

Authors:  N Robin; G Gill; C van Heyningen; W Fraser
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

7.  Sinonasal Phosphaturic Mesenchymal Tumor: A Rare and Misinterpreted Entity.

Authors:  Demetri Arnaoutakis; Iman Naseri
Journal:  J Neurol Surg Rep       Date:  2015-08-21

8.  An interesting case of reversible metabolic myopathy: Tumor induced osteomalacia.

Authors:  Hanmayyagari Babul Reddy; Guntaka Mounika; V Sri Nagesh; I Satish Rao
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

9.  Malignant phosphaturic mesenchymal tumor of the pelvis: A report of two cases.

Authors:  Tokimitsu Morimoto; Satoshi Takenaka; Nobuyuki Hashimoto; Nobuhito Araki; Akira Myoui; Hideki Yoshikawa
Journal:  Oncol Lett       Date:  2014-04-22       Impact factor: 2.967

10.  Sinonasal phosphaturic mesenchymal tumor: Case report and systematic review.

Authors:  Nicholas L Deep; Rachel B Cain; Ann E McCullough; Joseph M Hoxworth; Devyani Lal
Journal:  Allergy Rhinol (Providence)       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.